Skip to main content
SpringerLink
Log in

Rofecoxib gets a head start on celecoxib in France

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rofecoxib gets a head start on celecoxib in France. Pharmacoecon. Outcomes News 261, 11 (2000). https://doi.org/10.1007/BF03267097

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03267097

Keywords

Search

Navigation